Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Jul;57(7):623–628. doi: 10.1136/thorax.57.7.623

Raised plasma concentrations of α-defensins in patients with idiopathic pulmonary fibrosis

H Mukae 1, H Iiboshi 1, M Nakazato 1, T Hiratsuka 1, M Tokojima 1, K Abe 1, J Ashitani 1, J Kadota 1, S Matsukura 1, S Kohno 1
PMCID: PMC1746385  PMID: 12096207

Abstract

Background: Neutrophils are thought to play an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Human neutrophils contain antimicrobial and cytotoxic peptides in the azurophil granules which belong to a family of mammalian neutrophil peptides named α-defensins. A study was undertaken to investigate the role of α-defensins in the pathogenesis of IPF.

Methods: The concentrations of α-defensins (human neutrophil peptides (HNPs) 1, 2, and 3) in plasma and bronchoalveolar lavage (BAL) fluid of 30 patients with IPF and 15 healthy subjects were measured by radioimmunoassay.

Results: The concentrations of α-defensins in plasma, but not in BAL fluid, were significantly higher in IPF patients than in controls. BAL fluid concentrations of interleukin (IL)-8 in patients with IPF, which were significantly higher than in controls, correlated with those of α-defensins. An inverse relationship was seen between plasma α-defensin levels and the arterial oxygen tension (PaO2) and pulmonary function (vital capacity (%VC), forced expiratory volume in 1 second (FEV1), and carbon monoxide transfer factor (%TLCO)) in patients with IPF. Plasma levels of α-defensins also correlated with the clinical course in IPF patients with an acute exacerbation. Immunohistochemically, positive staining was observed inside and outside neutrophils in the alveolar septa, especially in dense fibrotic areas.

Conclusion: These findings suggest that α-defensins play an important role in the pathogenesis of IPF, and that the plasma α-defensin level may be a useful marker of disease severity and activity.

Full Text

The Full Text of this article is available as a PDF (228.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agusti C., Xaubet A., Luburich P., Ayuso M. C., Roca J., Rodriguez-Roisin R. Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis. Thorax. 1996 Aug;51(8):841–845. doi: 10.1136/thx.51.8.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):646–664. doi: 10.1164/ajrccm.161.2.ats3-00. [DOI] [PubMed] [Google Scholar]
  3. Ashitani J., Mukae H., Hiratsuka T., Nakazato M., Kumamoto K., Matsukura S. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection. Chest. 2001 Apr;119(4):1131–1137. doi: 10.1378/chest.119.4.1131. [DOI] [PubMed] [Google Scholar]
  4. Ashitani J., Mukae H., Nakazato M., Ihi T., Mashimoto H., Kadota J., Kohno S., Matsukura S. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur Respir J. 1998 Jan;11(1):104–111. doi: 10.1183/09031936.98.11010104. [DOI] [PubMed] [Google Scholar]
  5. Ashitani J., Mukae H., Nakazato M., Taniguchi H., Ogawa K., Kohno S., Matsukura S. Elevated pleural fluid levels of defensins in patients with empyema. Chest. 1998 Mar;113(3):788–794. doi: 10.1378/chest.113.3.788. [DOI] [PubMed] [Google Scholar]
  6. Ashitani J., Mukae H., Taniguchi H., Ihi T., Kadota J., Kohno S., Matsukura S. Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Thorax. 1999 Nov;54(11):1015–1020. doi: 10.1136/thx.54.11.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ashitani J., Nakazato M., Mukae H., Taniguchi H., Date Y., Matsukura S. Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia. Regul Pept. 2000 Nov 24;95(1-3):87–92. doi: 10.1016/s0167-0115(00)00158-0. [DOI] [PubMed] [Google Scholar]
  8. Boomars K. A., Wagenaar S. S., Mulder P. G., van Velzen-Blad H., van den Bosch J. M. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. Thorax. 1995 Oct;50(10):1087–1092. doi: 10.1136/thx.50.10.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Date Y., Nakazato M., Shiomi K., Toshimori H., Kangawa K., Matsuo H., Matsukura S. Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. Ann Hematol. 1994 Aug;69(2):73–77. doi: 10.1007/BF01698485. [DOI] [PubMed] [Google Scholar]
  10. Fujita J., Yamadori I., Kamei T., Yamaji Y., Takahara J. Neutrophilic endotheliitis in patients with idiopathic pulmonary fibrosis. Chest. 1995 Aug;108(2):589–589. doi: 10.1378/chest.108.2.589. [DOI] [PubMed] [Google Scholar]
  11. Ganz T., Lehrer R. I. Defensins. Curr Opin Immunol. 1994 Aug;6(4):584–589. doi: 10.1016/0952-7915(94)90145-7. [DOI] [PubMed] [Google Scholar]
  12. Hunninghake G. W., Kawanami O., Ferrans V. J., Young R. C., Jr, Roberts W. C., Crystal R. G. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):407–412. doi: 10.1164/arrd.1981.123.4.407. [DOI] [PubMed] [Google Scholar]
  13. Ihi T., Nakazato M., Mukae H., Matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997 Nov;25(5):1134–1140. doi: 10.1086/516075. [DOI] [PubMed] [Google Scholar]
  14. Kobayashi J., Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 1995 Aug;108(2):311–315. doi: 10.1378/chest.108.2.311. [DOI] [PubMed] [Google Scholar]
  15. Lynch J. P., 3rd, Standiford T. J., Rolfe M. W., Kunkel S. L., Strieter R. M. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis. 1992 Jun;145(6):1433–1439. doi: 10.1164/ajrccm/145.6.1433. [DOI] [PubMed] [Google Scholar]
  16. Mukae H., Kadota J., Kohno S., Kusano S., Morikawa T., Matsukura S., Hara K. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med. 1995 Aug;152(2):613–618. doi: 10.1164/ajrccm.152.2.7633715. [DOI] [PubMed] [Google Scholar]
  17. Nakazato M., Shiomi K., Date Y., Matsukura S., Kangawa K., Minamino N., Matsuo H. Isolation and sequence determination of 6- and 8-kDa precursors of human neutrophil peptides from bone marrow, plasma and peripheral blood neutrophils. Biochem Biophys Res Commun. 1995 Jun 26;211(3):1053–1062. doi: 10.1006/bbrc.1995.1918. [DOI] [PubMed] [Google Scholar]
  18. Obayashi Y., Yamadori I., Fujita J., Yoshinouchi T., Ueda N., Takahara J. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest. 1997 Nov 5;112(5):1338–1343. doi: 10.1378/chest.112.5.1338. [DOI] [PubMed] [Google Scholar]
  19. Okrent D. G., Lichtenstein A. K., Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis. 1990 Jan;141(1):179–185. doi: 10.1164/ajrccm/141.1.179. [DOI] [PubMed] [Google Scholar]
  20. Panyutich A. V., Panyutich E. A., Krapivin V. A., Baturevich E. A., Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993 Aug;122(2):202–207. [PubMed] [Google Scholar]
  21. Schwartz D. A., Helmers R. A., Galvin J. R., Van Fossen D. S., Frees K. L., Dayton C. S., Burmeister L. F., Hunninghake G. W. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):450–454. doi: 10.1164/ajrccm.149.2.8306044. [DOI] [PubMed] [Google Scholar]
  22. Schwartz D. A., Van Fossen D. S., Davis C. S., Helmers R. A., Dayton C. S., Burmeister L. F., Hunninghake G. W. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):444–449. doi: 10.1164/ajrccm.149.2.8306043. [DOI] [PubMed] [Google Scholar]
  23. Shiomi K., Nakazato M., Ihi T., Kangawa K., Matsuo H., Matsukura S. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Commun. 1993 Sep 30;195(3):1336–1344. doi: 10.1006/bbrc.1993.2190. [DOI] [PubMed] [Google Scholar]
  24. Soong L. B., Ganz T., Ellison A., Caughey G. H. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res. 1997 Mar;46(3):98–102. doi: 10.1007/s000110050114. [DOI] [PubMed] [Google Scholar]
  25. Southcott A. M., Jones K. P., Li D., Majumdar S., Cambrey A. D., Pantelidis P., Black C. M., Laurent G. J., Davies B. H., Jeffery P. K. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med. 1995 May;151(5):1604–1612. doi: 10.1164/ajrccm.151.5.7735620. [DOI] [PubMed] [Google Scholar]
  26. Suga M., Iyonaga K., Okamoto T., Gushima Y., Miyakawa H., Akaike T., Ando M. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2000 Nov;162(5):1949–1956. doi: 10.1164/ajrccm.162.5.9906096. [DOI] [PubMed] [Google Scholar]
  27. Takahashi H., Fujishima T., Koba H., Murakami S., Kurokawa K., Shibuya Y., Shiratori M., Kuroki Y., Abe S. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1109–1114. doi: 10.1164/ajrccm.162.3.9910080. [DOI] [PubMed] [Google Scholar]
  28. Taooka Y., Maeda A., Hiyama K., Ishioka S., Yamakido M. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 1997 Jul;156(1):260–265. doi: 10.1164/ajrccm.156.1.9612077. [DOI] [PubMed] [Google Scholar]
  29. Turner-Warwick M., Haslam P. L. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1987 Jan;135(1):26–34. doi: 10.1164/arrd.1987.135.1.26. [DOI] [PubMed] [Google Scholar]
  30. Wells A. U., Hansell D. M., Haslam P. L., Rubens M. B., Cailes J., Black C. M., du Bois R. M. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1474–1482. doi: 10.1164/ajrccm.157.5.9609096. [DOI] [PubMed] [Google Scholar]
  31. Westlin W. F., Gimbrone M. A., Jr Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol. 1993 Jan;142(1):117–128. [PMC free article] [PubMed] [Google Scholar]
  32. Yamanouchi H., Fujita J., Hojo S., Yoshinouchi T., Kamei T., Yamadori I., Ohtsuki Y., Ueda N., Takahara J. Neutrophil elastase: alpha-1-proteinase inhibitor complex in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Eur Respir J. 1998 Jan;11(1):120–125. doi: 10.1183/09031936.98.11010120. [DOI] [PubMed] [Google Scholar]
  33. Ziegenhagen M. W., Zabel P., Zissel G., Schlaak M., Müller-Quernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):762–768. doi: 10.1164/ajrccm.157.3.9705014. [DOI] [PubMed] [Google Scholar]
  34. van Wetering S., Sterk P. J., Rabe K. F., Hiemstra P. S. Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol. 1999 Dec;104(6):1131–1138. doi: 10.1016/s0091-6749(99)70004-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES